Caladrius Biosciences Stock
NASDAQ:CLBS Delisted Open Broker Account

$3.55 (1.14%)

Volume: 0

Closed: Jan 27, 2023

Hollow Logo Score: 0.000
Caladrius Biosciences Stock
Open Broker Account NASDAQ:CLBS Delisted
$3.55 (1.14%)

Volume: 0

Closed: Jan 27, 2023

Score Hollow Logo 0.000
NASDAQ:CLBS

Caladrius Biosciences Stock Price (Quote)

$3.55 ( 1.14% ) Friday, 27th Jan 2023

Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
2023-01-27 $3.50 $3.55 $3.50 $3.55 0
2023-01-26 $3.60 $3.60 $3.51 $3.51 0
2023-01-25 $3.66 $3.71 $3.56 $3.63 0
2023-01-24 $3.61 $3.81 $3.61 $3.71 0
2023-01-23 $3.50 $3.68 $3.50 $3.64 0
2023-01-20 $3.40 $3.57 $3.40 $3.49 0
2023-01-19 $3.38 $3.50 $3.38 $3.49 0
2023-01-18 $3.63 $3.63 $3.47 $3.47 0
2023-01-17 $3.64 $3.67 $3.50 $3.62 0
2023-01-13 $3.53 $3.70 $3.53 $3.65 0
2023-01-12 $3.21 $3.65 $3.21 $3.58 0
2023-01-11 $3.19 $3.20 $3.11 $3.20 0
2023-01-10 $3.00 $3.20 $3.00 $3.20 0
2023-01-09 $2.92 $3.03 $2.90 $3.00 0
2023-01-06 $2.99 $3.02 $2.97 $3.00 0
2023-01-05 $4.87 $4.87 $4.87 $4.87 0
2023-01-04 $4.87 $4.87 $4.87 $4.87 0
2023-01-03 $4.87 $4.87 $4.87 $4.87 0
2022-12-30 $4.87 $4.87 $4.87 $4.87 0
2022-12-29 $4.87 $4.87 $4.87 $4.87 0
2022-12-28 $4.87 $4.87 $4.87 $4.87 0
2022-12-27 $4.87 $4.87 $4.87 $4.87 0
2022-12-23 $4.87 $4.87 $4.87 $4.87 0
2022-12-22 $4.87 $4.87 $4.87 $4.87 0
2022-12-21 $4.87 $4.87 $4.87 $4.87 0
2022-12-20 $4.87 $4.87 $4.87 $4.87 0
2022-12-19 $4.87 $4.87 $4.87 $4.87 0
2022-12-16 $4.87 $4.87 $4.87 $4.87 0
2022-12-15 $4.87 $4.87 $4.87 $4.87 0
2022-12-14 $4.87 $4.87 $4.87 $4.87 0
2022-12-13 $4.87 $4.87 $4.87 $4.87 0
2022-12-12 $4.87 $4.87 $4.87 $4.87 0
2022-12-09 $4.87 $4.87 $4.87 $4.87 0
2022-12-08 $4.87 $4.87 $4.87 $4.87 0
2022-12-07 $4.87 $4.87 $4.87 $4.87 0
2022-12-06 $4.87 $4.87 $4.87 $4.87 0
2022-12-05 $4.87 $4.87 $4.87 $4.87 0
2022-12-02 $4.87 $4.87 $4.87 $4.87 0
2022-12-01 $4.87 $4.87 $4.87 $4.87 0
2022-11-30 $4.87 $4.87 $4.87 $4.87 0
2022-11-29 $4.87 $4.87 $4.87 $4.87 0
2022-11-28 $4.87 $4.87 $4.87 $4.87 0
2022-11-25 $4.87 $4.87 $4.87 $4.87 0
2022-11-23 $4.87 $4.87 $4.87 $4.87 0
2022-11-22 $4.87 $4.87 $4.87 $4.87 0
2022-11-21 $4.87 $4.87 $4.87 $4.87 0
2022-11-18 $4.87 $4.87 $4.87 $4.87 0
2022-11-17 $4.87 $4.87 $4.87 $4.87 0
2022-11-16 $4.87 $4.87 $4.87 $4.87 0
2022-11-15 $4.87 $4.87 $4.87 $4.87 0

Hot Stocks To Watch:

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT